Benaroya Research Institute Seafair Triathlon Supports Research
The 2018 Benaroya Research Institute Seafair Triathlon, taking place on July 22 at Seward Park, offers participants multiple events on a picturesque course while raising funds and awareness for Benaroya Research Institute at Virginia Mason (BRI).
This is a unique opportunity to participate in an Olympic, sprint or kids distance triathlon all while making an impact in autoimmune disease research.
Athletes will have the option to fundraise and participate in medical research through BRI’s biorepositories. Funds raised will be invested in promising young scientists, novel ideas and technology tools that lead to life-saving breakthroughs in chronic, lifelong diseases such as type 1 diabetes, multiple sclerosis, Crohn’s disease, and rheumatoid arthritis.
Together, we are making important progress against all autoimmune diseases. Your support will fund more breakthroughs that hold the promise of life-saving cures.
You Might Also Like
Innovation Fund Spotlight: New Tool Enables Scientists to Collect More Data From Rare Cells
Scientists know that cells of the immune system attack healthy tissue in autoimmune disease. But they don’t know exactly when those cells go awry, what drives them toward disease or if that process can be slowed or stopped to prevent disease. BRI has been instrumental in research that led to the first medicine to delay the onset of type 1 diabetes. Now, Peter Morawski, PhD, and Arpit Mishra, PhD, are building on that work and exploring early intervention in other autoimmune diseases.
Innovation Fund Spotlight: Finding the Precise Moment When Immune Cells Start Causing Disease
Autoimmune diseases happen when immune cells, which are supposed to protect you from germs, mistakenly attack healthy tissues. But what if we knew exactly which immune cells would attack – and when? Could we stop that attack before it starts? BRI’s John Ray, PhD, and Oliver Harrison, DPhil, are exploring exactly that.
Eddie Irvine, PhD, Uses Engineering and AI to Explore Big Questions in Immunology
Eddie Irvine, PhD, recently joined BRI as a Principal Investigator in the Center for Systems Immunology. He’ll use his unique background in protein engineering and AI to better understand the immune system and find new ways to treat disease.
Immuno-what? Hear the latest from BRI
Keep up to date on our latest research, new clinical trials and exciting publications.